“…Thus, in comparison with immunoassays based on traditional chemically synthesized antigens, novel developed detection methods employing biosynthetic antigens of VHHs display preferable cost advantages and product stability, so they are suitable for commercial production and widespread use. Accordingly, several anti-idiotypic VHHs (AI-VHHs), including those for mycotoxin zearalenone, fumonisin B 1 , aflatoxin B 1 , Ochratoxin A, deoxynivalenol (DON), and other toxins, have been developed as toxin surrogates in immunoassays (Hao et al, 2020;Liu et al, 2018;Qiu et al, 2016;Shu et al, 2019;Wang et al, 2013;Wang et al, 2016;Zhang et al, 2019). However, these determination methods for mycotoxin surveillance only avoid the application one of the chemically synthetized mycotoxin conjugates or mycotoxin detection standard.…”